Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
525 participants
OBSERVATIONAL
2020-11-04
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy
NCT04377490
Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels
NCT04373486
Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy
NCT04366752
COVID-19, bLOod Coagulation and Thrombosis
NCT04388657
Does COVID-19 Infection Increase the Risk of Pulmonary Embolism?
NCT04696913
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID 19 patients
all patients with positive SARS-CoV 2 swap
duplex sonography
all patients with consent receive a duplex ultrasound, blood test, cognitive test and test of smelling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
duplex sonography
all patients with consent receive a duplex ultrasound, blood test, cognitive test and test of smelling
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Augsburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexander Hyhlik-Dürr
Head of department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Hyhlik-Duerr, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Augsburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Augsburg
Augsburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Schmidbauer L, Kirchberger I, Gosslau Y, Warm TD, Hyhlik-Durr A, Linseisen J, Meisinger C. The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting. J Neurol. 2023 Jul;270(7):3294-3302. doi: 10.1007/s00415-023-11752-9. Epub 2023 May 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID Thrombose
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.